Nephrology Fellowship Program

Banner

Message from Program Director

Dear future Nephrology fellows,

I would like to welcome you to our program and share with you information about the learning experience offered by our Nephrology Fellowship program. The Nephrology Fellowship sponsored by Westchester Medical Center, in affiliation with New York Medical College, is an ACGME-accredited, two-year program that provides fellows with the opportunity to learn all aspects of Nephrology (Clinical Nephrology, Critical Care Nephrology, Renal Transplantation and Basic Science Renal Research) from our diverse and talented faculty. The program also offers a three-year specialized Nephrology- Critical Care Track for those individuals with a special interest.

Training occurs at Westchester Medical Center (WMC), the main university hospital of New York Medical College, known for one of the highest case mix index rates of all hospitals in the United States. The hospital is the well established flagship hospital of WMC Health Network and is equipped with advanced technology, academic expertise, and educational support.

Our trainees also rotate in the Outpatient Dialysis Facility and Basic Science Renal Research lab at New York Medical College, both on the same campus. The conference and rounding schedules evidence the commitment of the Division to the education of our fellows. All activities are appropriately supervised and designed to provide the trainees with competence in all renal procedures inclusive of point of care ultrasonography.

You can learn more about the program from this website. Applications are submitted through the ERAS Application Process; we participate as an All-In-Specialty in the National Resident Matching Program. Refer to our information on “How to Apply.” For more specific. We look forward to your interest in our program.

Sincerely,


Savneek Singh Chugh, MD, FACP, FASN
Program Director
Associate Professor of Medicine
Nephrology Fellowship Program

Message from Chief of the Division of Nephrology at Westchester Medical Center

The Division of Nephrology has 11 full-time clinical faculty members within the Westchester Medical Center Health Network. Additional Professional staff include Attending Physicians, fellows, residents, and medical students, who participate in all aspects of inpatient and outpatient care. Clinical care is provided with a pathophysiological approach. Team members are actively involved in clinical and basic science research, where they participate in NIH and industry-sponsored research involving chronic kidney disease, transplantation and dialysis disorders.

The Renal Team provides the entire scope of advanced Critical Care Nephrology, including continuous and intermittent dialysis supporting our Trauma, Burn, Surgical, Medical, and Cardiothoracic Intensive Care Units, including patients on ECMO and heart assist devices. More than 2,500 kidney transplants have been performed at WMC. The Renal Team provides primary nephrology and consulting services for all of transplantation, including kidney-heart and kidney-liver tandem transplants. As a result, more than 6,000 inpatient hemodialysis treatments are done each year at WMC.

Attending Nephrologists also conduct more than 35,000 outpatient dialysis treatments. All forms of chronic dialysis treatment, including home hemodialysis and home peritoneal dialysis, are available.

An array of complex Nephrology cases in different clinical settings, accompanied by our outstanding Faculty, affords trainees an excellent educational experience. Trainees will be expected to not only become excellent clinicians, but to learn about all aspects of Nephrology and participate in national and international conferences.

The program provides abundant opportunity for clinical and basic science research, scholarly activities, publications and participation in clinical trials. Our trainees have consistently presented, published and excelled in their careers after graduation.

 

Nephrology / Critical Care Track

Our dual program is for those interested in achieving board certification in both Nephrology and Critical Care Medicine. It is a combined three-year program and one of the few programs directed by a renal intensivist (Dr. Coritsidis, Director, Nephrology-Critical Care Track). To apply to this specific program simply identify your interest on your application. The interview process will include the Program Director as well as an intensivist.

WMC offers an exceptional opportunity to be an excellent provider in both specialties. The 795-bed hospital includes 9 ICUs ( Neuro, Cardiothoracic, Surgical, Medical, Burn, Trauma as well as the CCU which collectively accounts for over 80 beds ). WMC also supports a comprehensive Transplant service for heart, kidney and liver transplant further rounding out the experience.

The breadth and depth of the Critical Care experience allows the fellow to become proficient the care of critically-ill transplant patients, ultrasonography, ECMO and renal replacement therapies (CVVHD, SLEDD). Academic responsibilities will include journal club and case presentations as well as research projects.

The three-year program provides comprehensive exposure to the required academics in Nephrology while learning Critical Care Medicine. Heavily oriented towards Nephrology in the first two years of the program, it provides the fellow the opportunity to sit for Nephrology subspecialty boards after the second year, and the Critical Care subspecialty boards after graduation.

 

Transplant

The Kidney Transplant Program opened its doors in 1989 and has transplanted over 2500 patients since that time. We utilize a multidisciplinary team and patient-focused approach to evaluate and provide care to patients and their families, regardless of their economic, geographic, racial, or ethnic background.

 

Goals of Training

The fundamental goals and objectives of the Nephrology Training Program are to provide advanced education and experience to enable fellows to deliver compassionate, thorough, and evidence-based care to a medically and socially diverse population of patients. This includes inpatient and outpatient consultation; acute and chronic dialysis, including continuous modalities; chronic kidney disease care, including the care of patients with glomerular diseases; and the care for renal allograft recipients. The fellow will be provided with educational opportunities required for acquiring Board Certification in the subspecialty of Nephrology and, where applicable, Critical Care. Fellows can be mentored towards an academic clinical or basic science research career if interested. The philosophy of the program is to develop a commitment and dedication to scholarly excellence in patient care, teaching, and research in an environment of professionalism.

 

Fellows Life

Our fellows have the opportunities to present and attend different academic conferences including the NKF (National Kidney Foundation), (SCCM) Society of Critical Care Medicine and ASN (American Society of Nephrology) meetings. Westchester County and the Hudson Valley is well known for outdoor and nature inspired experiences, with access to rock climbing, hiking and skiing. The campus is less than 30 minutes from New York City.

Fellows’ wellbeing is supported by regular group gatherings in and outside the hospital. We take fellows’ wellness very seriously and continue to improve the program while taking advantage of comprehensive benefits and our own GME-focused wellness initiatives.

 

Rotations

 

First Year General Nephrology Fellow Rotations *

Inpatient Clinical (Consult Service)

20 weeks

Transplant Service Rotation

8 weeks

Research/Elective

12 weeks

Dialysis

8 weeks

Vacation

4 weeks

 

Second Year General Nephrology Fellow Rotations*

Inpatient Clinical (Consult Service)

8 weeks

Transplant Service Rotation

8 weeks

Research/Elective

24 weeks

Dialysis

8 weeks

Vacation

4 weeks

*Please note, although these are the typical rotations for our fellows, schedules are subject to change.

 

 

First Year Nephrology Critical Care Fellow Rotations

Inpatient Clinical (Consult Service)

20 weeks

Transplant Service Rotation

4 weeks

Research/Elective

8 weeks

Dialysis

12 weeks

Vacation

4 weeks

Intensive care units

4 weeks

 

Second Year Nephrology Critical Care Fellow Rotations

Inpatient Clinical (Consult Service)

12 weeks

Transplant Service Rotation

4 weeks

Research/Elective

8 weeks

Dialysis

12 weeks

Intensive care units

12 weeks

Vacation

4 weeks

 

Third Year Nephrology Critical Care Fellow Rotations

Inpatient Clinical (Consult Service)

8 weeks

Intensive care units

24 weeks

Research/Elective

8 weeks

Dialysis

8 weeks

Vacation

4 weeks



Nephrology Fellows for 2023-2024


Second Year Fellows:


William Assante, MD
Residency: Westchester Medical Center, NY


Francis Atemnkeng, MD
Residency: Richmond University Medical Center, VA


Michelle Kirk, MD
Residency: Michigan State University Health Care, MI

 

First Year Fellows:

Shlomo Greenberg, MD
Residency: Icahn School of Medicine at Mount Sinai

 


Hiroki Nishimura, MD
Residency: Naval Medical Center (San Diego) Program

 

Caitlin Richardson-Royer, MD
Residency: Jewish Hospital of Cincinnati Program

 

Program Alumni

 

Class of 2023

 

Miniolla Durosier, MD
New York Medical College - Metropolitan Hospital, NY

 

Uzma Malik, MD
Residency: Nassau University Medical Center, NY


Mobolaji Ayodeji Obayomi, MD
Residency: Winthrop University Hospital, NY

 

Isaac Pak, DO
Residency: Garnet Health Medical Center, NY

 

Class of 2022

 

Jiwanjot Kaur Narula, MD
Private Practice
New York, NY

 

Kiran Shivaraj, MD
Transplant Nephrology Fellow
University of Miami, FL 

 

Class of 2021

 

Viviam Rivera Becerra, MD

Northern Light Eastern Maine Medical Center

Bangor, ME

 

Aulio Hemer Bustos, MD

Northern Light Eastern Maine Medical Center

Bangor, ME

 

Jennifer Griffiths, MD

MidHudson Regional Hospital - Westchester Medical Center Health Network

 

Hay Me Me, MBBS

Transplant Nephrology Fellow

Mayo Clinic in Arizona

 

 

Class of 2020

 

Thomas Anders Brevik, MD (Chief Fellow)

Private Practice

Denver, CO

 

Michael Connery, MD, PhD

Bon Secours Medical Group - Westchester Medical Center Health Network

Suffern, NY

 

 

Class of 2019

 

Nazrul Chowdhury, MD (Chief Fellow 7/2018-12/2018)

Private Practice

Clinton, SC

 

Nathalie Jean, MD

Transplant Nephrology Fellow

University of Chicago, IL

 

Samer Kareem, MBBS (Chief Fellow 1/2019-6/20)

Transplant Nephrology Fellow

State University of NY at Buffalo School of Medicine, NY

 

Class of 2018

 

Magdi Abdelrahman, MBBS

Private Practice

Qatar

 

Celeste Chang, MBBS

Private Practice

New York, NY

 

Sanjeev Gupta, MD, FACP, FASN

Nephrology Faculty

New York Medical College - Westchester Medical Center, NY

 

Anastasios Papanagnou, MD

Nephrology Faculty

Mount Sinai Hospital, NY

 

Stephen Adler, MD
Professor of Medicine and Physiology 

Dr. Adler went to Cornell University for undergraduate studies and graduated from N.Y.U school of medicine. He did his post graduate studies at Mount Sinai Medical Center, NY and Boston University Medical Center. Dr. Adler joined the Division of Nephrology of New York Medical College in 1986 as an Associate Professor after spending four years at the University of Washington in Seattle with the noted nephrologists; Drs. Belding Scribner and William G. Couser. Dr. Adler has been active in basic research, clinical trials, division administration, teaching and patient care. He helped establish the Faculty Practice of the Division of Nephrology and directed it for over 20 years prior to joining Advanced Physician Services at Westchester Medical Center. Currently, Dr. Adler is Medical Director of the Westchester Artificial Kidney Center/DCI and still participates in administration, teaching and patient care in the Division. He has a joint appointment in the Department of Physiology and has collaborated with Dr. T. Hintze, Chairman of Physiology, on studies of renal NO production in disease and aging. Dr. Adler participates in didactic teaching of fellows in addition to acting as a teaching attending on the inpatient consultative service and participating in the outpatient and dialysis programs of the Division. He has done investigative work in immunologic kidney disease, the role of oxidant stress in aging and hypertension and more recently clinical trials involving control of bone/mineral metabolism in dialysis patients and prevention of progression of Polycystic Kidney Disease. 

Dr. Savneek Singh Chugh
Savneek Singh Chugh, MD, MPH, FACP, FASN
Associate Professor of Medicine

Program Director, Nephrology Fellowship
After receiving his medical degree from Delhi University, Dr. Chugh completed his Internal Medicine Residency and Nephrology fellowship at Westchester Medical Center and New York Medical College (NYMC). He went on to serve as a faculty member with a current position of Director of Nephrology Fellowship at Westchester Medical Center and New York Medical College. Dr. Chugh also holds a Faculty Appointment at New York Medical College at the rank of Associate Professor of Medicine. Throughout his training and career, he has published and presented widely on a number of Nephrology topics with special interest on Acute Kidney Injury. He is the author of over 20 peer-reviewed papers, reviews, book chapters, and has over 50 abstracts presented at various international meetings including the American Society of Nephrology.  Dr. Chugh is the recipient of multiple awards for excellence in teaching residents and medical students at Westchester Medical Center and New York Medical College. His major areas of interest are studying and understanding the pathophysiology of acute kidney injury in hospitalized patients and thrombotic microangiopathies. His current research projects include identifying and mitigating acute kidney injury and the ICU and he is the site Principal Investigator for clinical trials on COVID-19 and FSGS at Westchester Medical Center. 


George Nicholas Coritsidis, MD, FACP
Professor of Medicine

Program Director, Critical Care Nephrology Fellowship Track 
Board certified in both renal and critical care, Dr. Coritsidis is a product of SUNY Upstate Medical Center in Syracuse and did his Nephrology fellowship at the Albert Einstein College of Medicine. He is Professor of Medicine, recently transferring from Elmhurst Hospital Center (EHC), part of the Mount Sinai System in New York. He is the current Director of the new Nephrology Critical Care program track and Director of Translational Research.
His experience includes that of Director of the Surgical/Trauma Intensive Care Unit at EHC, Program Director and Chief of Nephrology at EHC and key faculty at the Mt Sinai Critical Care Fellowship. He initiated one of the first fellowship programs offering dual training in Nephrology (two years) and Critical care (one year) over ten years ago, and has organized peritoneal dialysis programs in two different hospital settings. At WMC, he directs a similar dual program combining Nephrology and Critical Care over three  years. Dr. Coritsidis is currently the IPRO ESRD Network Two Chairman of the Divisional Board of Directors.
Dr. Coritsidis’ clinical and research interests include socioeconomic influences in dialysis; infections and antibiotics in ESRD; the utilization of ultrasound to assess fistula maturity, COVID effects on the dialysis population, acute kidney injury and its treatment, massive transfusion and critical care in general.


Anjani Dubey, MD
Assistant Professor of Medicine

Dr. Dubey is an Assistant Professor of Medicine on faculty at  New York Medical College. She is also an attending on staff in the Department of Medicine, Division of Nephrology at Westchester Medical Center in Valhalla, N.Y and White Plains Hospital, White Plains , N.Y.  Dr. Dubey is Board Certified in Internal Medicine and Nephrology  and is a member of the American College of Physicians, American Society of Nephrology, National Kidney Foundation and the International Society of Peritoneal Dialysis. She serves as Medical Director of the Home/Peritoneal Dialysis Program at DCI and has served as Medical Director of the Yorktown Artificial Kidney Center from its inception in 2000 to 2015 and the St. Agnes Dialysis Center from 1997 to 2005. Over the years, she has taught medical students, residents and fellows on a variety of topics in Internal Medicine and Nephrology and serves as a member of the Continuous Quality Improvement Committee at Westchester Medical Center. Her research interests include quality improvement and advances in hemodialysis and peritoneal dialysis.

Dr. Renee Garrick
Renee Garrick, MD, FACP, FASN
Executive Medical Director
Vice Dean and Professor of Clinical Medicine

Dr. Garrick is a practicing nephrologist with over 30 years’ experience. She is the Executive Medical Director of Westchester Medical Center, a public benefit hospital, and Chief Medical Officer of Westchester Health Network, a 1,700 bed academic health system with hospitals and offices in Westchester and the Hudson Valley.  As CMO of Westchester Health Network, Dr. Garrick  oversees quality, safety, and regulatory initiatives for the Health Network, and has extensive experience with quality initiatives as they relate to patients with kidney disease. Dr. Garrick currently serves as the medical director of a non-profit dialysis facility and previously chaired the NY State Task Force on dialysis care. She serves on the Quality Steering Committee of Healthcare Association of New York State (HANYS), and on the New York State Department of Health Quality Advisory Committee for Office Based Surgery. Dr. Garrick currently serves on NQF Renal Standing Committee and has served on NQF Technical expert panels. She has participated in the creation of Patient Related Outcome Measures for patients with kidney disease.  Additionally, Dr. Garrick has served on the Divisional Board of IPRO- ESRD Network of New York, and is a past board member of the Renal Physicians Association, where she currently is a member of the Quality, Safety and Accountability Committee. Dr. Garrick  is a member of the ASN Nephrologist Transforming Dialysis Safety Workgroup and serves on a Data and Safety Monitoring Board of the NIH/NIDDK. 

Dr. Sanjeev Gupta
Sanjeev Gupta, MD, FACP, FASN
Assistant Professor of Medicine
Associate Program Director, Nephrology Fellowship

Dr. Gupta has completed his M.B.B.S degree from University College of Medical Sciences, New Delhi, India. After finishing medical school, he did his Internal Medicine Residency at Montefiore New Rochelle Hospital in NY. He completed his Nephrology fellowship at Westchester Medical Center in Valhalla NY and remained as a Nephrology Attending. Along with patient care, he is also involved in teaching and multiple research projects.  

Dr. Aromma Kapoor
Aromma Kapoor, MD
Assistant Professor of Medicine
Associate Program Director, Nephrology Fellowship

Dr. Aromma Kapoor received her medical degree from Kasturba Medical College, Manipal, India in 2004. She completed her internship and residency in Internal Medicine at SUNY/ Stonybrook University Medical Center in Long Island, NY. This was followed by a fellowship in Nephrology and Hypertension at Westchester Medical Center. Dr. Kapoor joined the faculty at New York Medical College in 2011 and is currently an Assistant Professor of Medicine and Nephrology. Her research interests include Acute Renal Failure and prevention of progression of Kidney Failure. Dr. Kapoor is a member of the American Medical Association and American Society of Nephrology. Dr. Kapoor is board certified in Internal Medicine and Nephrology.

Dr. Michael Klein
Michael D. Klein, MD
Professor of Medicine
Division Chief, Nephrology

Dr. Klein relocated from Chicago after graduating from the University Of Illinois College Of Medicine.  He did both his Internal Medicine residency and Nephrology Fellowship at Columbia Presbyterian Medical Center. While there, his house staff peers awarded him the Joseph Muschel Memorial House Staff Award for excellence in ethics and patient care.  He joined the faculty of New York Medical College in 1998, where he is currently holds the rank of  Associate Professor of Clinical Medicine. Dr. Klein  is known as an outstanding teacher and has been recognized repeatedly for his contributions to education in the medical school and the house staff training programs. He treats all forms of kidney disease but has special interests in dialysis, fluids and electrolytes, glomerular disease, and all stages of chronic kidney disease. Of note, Dr Klein is a member of the Illinois Bar Association, having earned a J.D. from the University of Illinois College of Law and has an additional special interest in medical ethics.


Amol Mittal, MD
Clinical Associate Professor of Medicine

Dr. Mittal is an attending physician in the department of Medicine, division of Nephrology at Westchester Medical Center and White Plains hospital & Clinical Assistant Professor of Medicine at New York Medical College.  He completed internal medicine residency from Cleveland Clinic Fairview Hospital and nephrology fellowship from Brown University after graduating medical school from the University of Delhi, India. He moved to Westchester after working as a Nephrologist for 2.5 years in Buffalo, NY in a nephrology practice affiliated with four hospitals of the region. He is ABIM board certified in Internal Medicine and Nephrology and an active member of American Society of Nephrology. He practices all aspects of nephrology with special interests in AKI and critical care nephrology. 

Dr. Daniel Glicklich
Daniel Glicklich, MD
Medical Director, Kidney Transplant

Having published more than 65 peer-reviewed papers, Dr. Glicklich is well known for his work and academic interest in complications and management of chronic renal failure following transplantation. He has a strong commitment to medical education and has trained more than 150 Nephrology fellows. Dr. Glicklich is the founding member of the New York Transplant Nephrology Consortium.
Medical School: Albert Einstein College of Medical School
Internship: Harlem Hospital and Medical Montefiore Medical Center
Residency: Harlem Hospital and Medical Montefiore Medical Center
Fellowship: Nephrology at Harlem Hospital and Medical Montefiore Medical Center


Nandita Singh, MD
Assistant Professor of Medicine

Dr. Nandita Singh is a transplant nephrologist who joined the Kidney Transplant Program at Westchester medical center from 2008 until 2016 and then returned in 2019.
Dr. Singh earned her medical degree from New York Institute of Technology/New York College of Osteopathic Medicine in 2002.  She completed her Internal medicine training at Beth Israel Medical Center/Albert Einstein College of Medicine. Following residency, Dr. Singh completed her fellowship training in nephrology at Jacobi Medical Center/Albert Einstein College of Medicine and went on to graduate from transplant nephrology fellowship at Westchester Medical Center/New York Medical College.
She is board certified in Internal Medicine and Nephrology.
Dr. Singh is an Assistant Professor of Medicine at New York Medical College and practicing transplant nephrology with the Kidney Transplant Center at Westchester Medical Center. She has over ten years of experience taking care of patients with Kidney Disease, Kidney Donors, Kidney transplant recipient, as well multi-organs recipients. Her interests include transplant immunology, management of Immunosuppression, mechanism of acute and chronic rejection, complications in patients with kidney transplants. 

Dr. Susmitha Dhanyamraju
Susmitha Dhanyamraju, MD
Associate Section Chief, Northern Region
Division of Nephrology

Jennifer Griffiths, MD
Attending, Nephrology

ASN Abstracts Accepted

Etiology of hyponatremia in COVID-19 patients compared to hyponatremia with non-COVID-19 patients by urine osmolarity and sodium
Authors: Isaac Pak, Miniolla Durosier Louis, Shruti Kore, James Beck, George N. Coritsidis

Overcorrection in the management of hyponatremic patients Na< 125 following emergency department admission
Authors: Isaac Pak, Miniolla Durosier Louis, Shruti Kore, James Beck, George N. Coritsidis

Pathogenic genes in the Mesoamerican ESRD population
Authors:  Mobolaji Obayomi, Jessie Fullmer, Shruti Kore,  Henry Fan, George N. Coritsidis

Use of Serum Osmolality to Guide Management of Severe Hyponatremia Outside of Detectable Range
Authors: ASSANTE

Steroid-Dependent Minimal Change Disease in an Adult Responsive to Rituximab
Authors: ASSANTE

Combined Diagnosis of Proliferative Lupus Nephritis and Tuberculosis Infection: A Treatment Dilemma.
AUTHORS: Francis N. Atemnkeng, Michelle L. Kirk, James M. Pullman, Michael D. Klein, Savneek S. Chugh, Sanjeev Gupta

Is Diabetic Ketoacidosis Synonymous with Death in Patients on Enfortumab Vedotin for Urothelial Carcinoma?
AUTHORS: Francis N. Atemnkeng, Fatima Aguilar, Savneek S. Chugh, Sanjeev Gupta, Michael D. Klein


PUBLICATIONS 2019-present:
1.             Kichloo, A., Chugh, S. S., Gupta, S., Pandav, J., & Chander, P. Atypical Hemolytic Uremic Syndrome Presenting as Acute Heart Failure—a Rare Presentation: Diagnosis Supported by Skin Biopsy (2019). Journal of Investigative Medicine High Impact Case Reports, 7, 2324709619842905. PMID: 31010328
 
2.             Asim Kichloo, MD, Savneek Singh Chugh, MD, Sanjeev Gupta MD, Jay Panday, MD, Ghazaleh Emedis Goldar, M. Tenofovir and Severe Symptomatic Hypophosphatemia. https://journals.sagepub.com/doi/full/10.1177/2324709619848796. PMID: 31142127
 
3.             Solanki, S., Haq, K.F., Khan, M., Chakinala, R., Mehta, S., Haq, K.S., Mansuri, U., Khan, Z., Gandhi, D., Singh, J. and Chugh, S.S., 2019. Gastrointestinal Hemorrhage in Acute Kidney Injury Patients on Hemodialysis. Cureus, 11(9). PMD: 31700754
 
4.             Depa J, Coritsidis GN. Recurrence of Minimal Change Disease (MCD) Following a Motor Vehicle Trauma –An Atypical Cause and Review of Literature. J Trauma Inj 2019; 32(2):111-114 https://doi.org/10.20408/jti.2018.048
 
5.             Coritsidis GN, Ram P, Miah F, Wyrick JM, Kalosza BA. Outcomes in Critically Ill Patients with Severe TBI: Ethnicity, Documentation and Insurance status. Crit Care Med 2020; 48: 31-40 doi: 10.1097/CCM.0000000000004043
 
6.             Coritsidis GN, Machado ON, Farzin Levi-Haim F, Yaphe S, Patel RA, Depa J. Point-of-Care Ultrasound for Assessing Arteriovenous Fistula Maturity in Outpatient Hemodialysis. Journal of Vascular Access April, 2020. doi.org/10.1177/1129729820913437
 
7.             Weiss S, Bhat P, Fernandez MP, Bhat JG, Coritsidis GN. COVID-19 Infection in End Stage Kidney Disease: Findings from a Prospective Disease Surveillance Program at Dialysis Facilities in New York City and Long Island. J Am Soc Nephrol, November 2020, 31 (11) 2517-2521; DOI: https://doi.org/10.1681/ASN.2020070932
 
8.             Kichloo, A., Amir, R., Aljadah, M., Wani, F., Solanki, S., Singh, J., & Chugh, S. S. (2020). FDG-PET versus PSMA-PET: A Patient with Prostate Cancer. Journal of investigative medicine high impact case reports, 8, 2324709620941313. https://doi.org/10.1177/2324709620941313 PMID: 32646251
 
9.             Chugh S, Solanki S, Singh J, Wolf DC, Chander PN. Acute Renal Failure in a Patient on Ledipasvir-Sofosbuvir Therapy for Hepatitis C. Am J Ther. 2020 Jul 31. doi: 10.1097/MJT.0000000000001144. Epub ahead of print. PMID: 32759622.
 
10.          Kichloo A, Albosta M, Dettloff K, Wani F, El-Amir Z, Singh J, Aljadah M, Chakinala RC, Kanugula AK, Solanki S, Chugh S. Telemedicine, the current COVID-19 pandemic and the future: a narrative review and perspectives moving forward in the USA. Fam Med Community Health. 2020 Aug;8(3):e000530. doi: 10.1136/fmch-2020-000530. PMID: 32816942; PMCID: PMC7437610.
 
11.          Chakinala RC, Solanki S, Haq KF, Singh J, Shah H, Solanki D, Kichloo A, Haq KS, Burney AH, Waqar S, Vyas M, Chugh S, Nabors C. Dieulafoy's Lesion: Decade-Long Trends in Hospitalizations, Demographic Disparity, and Outcomes. Cureus. 2020 Jul 13;12(7):e9170. doi: 10.7759/cureus.9170. PMID: 32802607; PMCID: PMC7424366.
 
12.          Kichloo, Asim, Rawan Amir, Michael Aljadah, Farah Wani, Shantanu Solanki, Jagmeet Singh, and Savneek Singh Chugh. "FDG-PET Versus PSMA-PET: A Patient with Prostate Cancer." Journal of Investigative Medicine High Impact Case Reports 8 (2020): 2324709620941313.
 
13.          Khadka, S., Solanki, D., Singh, J., Kichloo, A., Patel, N. R., Sharma, P., Chugh, S., & Solanki, S. (2020). Trends and outcomes of venous thromboembolism in adult hospitalizations with acute myeloid leukemia: Analysis of nationwide inpatient sample from 2010 to 2014. Postgraduate medicine, 10.1080/00325481.2020.1863717. Advance online publication. https://doi.org/10.1080/00325481.2020.1863717
 
14.          Chugh S, Singh J, Kichloo A, Gupta S, Katchi T, Solanki S. Uremic and Dialysis-Associated Pericarditis. Cardiol Rev. 2020 Dec 17. doi: 10.1097/CRD.0000000000000381. Epub ahead of print. PMID: 33337656.
 
15.          Hayek SS, Brenner SK, Azam TU, Shadid HR, Anderson E, Berlin H, Pan M, Meloche C, Feroz R, O'Hayer P, Kaakati R, Bitar A, Padalia K, Perry D, Blakely P, Gupta S, Shaefi S, Srivastava A, Charytan DM, Bansal A, Mallappallil M, Melamed ML, Shehata AM, Sunderram J, Mathews KS, Sutherland AK, Nallamothu BK, Leaf DE; STOP-COVID Investigators. In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study.  BMJ. 2020 Sep 30;371:m3513. doi: 10.1136/bmj.m3513. PMID: 32998872
 
16.          Molnar MZ, Bhalla A, Azhar A, Tsujita M, Talwar M, Balaraman V, Sodhi A, Kadaria D, Eason JD, Hayek SS, Coca SG, Shaefi S, Neyra JA, Gupta S, Leaf DE, Kovesdy CP; STOP-COVID Investigators. Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States.  Am J Transplant. 2020 Nov;20(11):3061-3071. doi: 10.1111/ajt.16280. Epub 2020 Sep 15. PMID: 32844546 Free PMC article
 
17.          Khadka S, Solanki D, Singh J, Kichloo A, Patel NR, Sharma P, Chugh S, Solanki S. Trends and outcomes of venous thromboembolism in adult hospitalizations with acute myeloid leukemia: analysis of nationwide inpatient sample from 2010 to 2014. Postgrad Med. 2021 Mar;133(2):160-165. doi: 10.1080/00325481.2020.1863717. Epub 2020 Dec 31. PMID: 33305685.
 
18.          Coritsidis GN, Lubowski T, Rahkman I, Yaphe S, Munro C, Stern A, ti Quan. Outpatient Antibiotic Patterns for Adult End Stage Renal Disease Patients in New York State. Accepted for publication to Clinical Infectious Diseases, 2021
 
19.          Coritsidis GN. Assessing COVID-19 in Patients with ESKD. Physician's Weekly; April Nephrology, 2021
 
20.          Coritsidis GN. Chapter XX:  Bedside Percutaneous Tracheotomy Wiley-Blackwell 2021 (in press)
 
21.          Mathews KS, Soh H, Shaefi S, Wang W, Bose S, Coca S, Gupta S, Hayek SS, Srivastava A, Brenner SK, Radbel J, Green A, Sutherland A, Leonberg-Yoo A, Shehata A, Schenck EJ, Short SAP, Chugh S, Hernán MA, Chan L, Leaf DE; Study of the Treatment and Outcomes in Critically Ill Patients with Coronavirus Disease (STOP-COVID) Investigators. Prone Positioning and Survival in Mechanically Ventilated Patients With Coronavirus Disease 2019-Related Respiratory Failure. Crit Care Med. 2021 Feb 17. doi: 10.1097/CCM.0000000000004938. Epub ahead of print. PMID: 33595960.
 
22.          Al-Samkari H, Gupta S, Leaf RK, Wang W, Rosovsky RP, Brenner SK, Hayek SS, Berlin H, Kapoor R, Shaefi S, Melamed ML, Sutherland A, Radbel J, Green A, Garibaldi BT, Srivastava A, Leonberg-Yoo A, Shehata AM, Flythe JE, Rashidi A, Goyal N, Chan L, Mathews KS, Hedayati SS, Dy R, Toth-Manikowski SM, Zhang J, Mallappallil M, Redfern RE, Bansal AD, Short SAP, Vangel MG, Admon AJ, Semler MW, Chugh S, Bauer KA, Hernán MA, Leaf DE; STOP-COVID-19 Investigators. Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19. Ann Intern Med. 2021 Jan 26:M20-6739. doi: 10.7326/M20-6739. Epub ahead of print. PMID: 33493012; PMCID: PMC7863679.
 
23.          Shaefi S, Brenner SK, Gupta S, O'Gara BP, Krajewski ML, Charytan DM, Chaudhry S, Mirza SH, Peev V, Anderson M, Bansal A, Hayek SS, Srivastava A, Mathews KS, Johns TS, Leonberg-Yoo A, Green A, Arunthamakun J, Wille KM, Shaukat T, Singh H, Admon AJ, Semler MW, Chugh S, Hernán MA, Mueller AL, Wang W, Leaf DE; STOP-COVID Investigators. Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19. Intensive Care Med. 2021 Feb;47(2):208-221. doi: 10.1007/s00134-020-06331-9. Epub 2021 Feb 2. PMID: 33528595; PMCID: PMC7851810.
24.          Gupta S, Wang W, Hayek SS, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, Reiser J, Bansal A, Srivastava A, Zhou Y, Finkel D, Green A, Mallappallil M, Faugno AJ, Zhang J, Velez JCQ, Shaefi S, Parikh CR, Charytan DM, Athavale AM, Friedman AN, Redfern RE, Short SAP, Correa S, Pokharel KK, Admon AJ, Donnelly JP, Gershengorn HB, Douin DJ, Semler MW, Hernán MA, Leaf DE; STOP-COVID Investigators. Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.   JAMA Intern Med. 2021 Jan 1;181(1):41-51. doi: 10.1001/jamainternmed.2020.6252. PMID: 33080002
 
25.          Gupta S, Coca SG, Chan L, Melamed ML, Brenner SK, Hayek SS, Sutherland A, Puri S, Srivastava A, Leonberg-Yoo A, Shehata AM, Flythe JE, Rashidi A, Schenck EJ, Goyal N, Hedayati SS, Dy R, Bansal A, Athavale A, Nguyen HB, Vijayan A, Charytan DM, Schulze CE, Joo MJ, Friedman AN, Zhang J, Sosa MA, Judd E, Velez JCQ, Mallappallil M, Redfern RE, Bansal AD, Neyra JA, Liu KD, Renaghan AD, Christov M, Molnar MZ, Sharma S, Kamal O, Boateng JO, Short SAP, Admon AJ, Sise ME, Wang W, Parikh CR, Leaf DE; and the STOP-COVID Investigators. AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19.  J Am Soc Nephrol. 2021 Jan;32(1):161-176. doi: 10.1681/ASN.2020060897. Epub 2020 Oct 16. PMID: 33067383
 
26.          Flythe JE, Assimon MM, Tugman MJ, Chang EH, Gupta S, Shah J, Sosa MA, Renaghan AD, Melamed ML, Wilson FP, Neyra JA, Rashidi A, Boyle SM, Anand S, Christov M, Thomas LF, Edmonston D, Leaf DE; STOP-COVID Investigators. Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States. Am J Kidney Dis. 2021 Feb;77(2):190-203.e1. doi: 10.1053/j.ajkd.2020.09.003. Epub 2020 Sep 19. PMID: 32961244 Free PMC article.
 
27.          Mathews KS, Soh H, Shaefi S, Wang W, Bose S, Coca S, Gupta S, Hayek SS, Srivastava A, Brenner SK, Radbel J, Green A, Sutherland A, Leonberg-Yoo A, Shehata A, Schenck EJ, Short SAP, Hernán MA, Chan L, Leaf DE; Study of the Treatment and Outcomes in Critically Ill Patients with Coronavirus Disease (STOP-COVID) Investigators. Prone Positioning and Survival in Mechanically Ventilated Patients With Coronavirus Disease 2019-Related Respiratory Failure. Crit Care Med. 2021 Feb 17. doi: 10.1097/CCM.0000000000004938. Online ahead of print. PMID: 33595960
 
28.          Gennarelli M, Jedynak A, Forman L, Wold E, Newman RB, Dhand A, Kapoor A, Jafri F, Pal S, Pandav J, Cho E, Devarajan A, Yandrapalli S, Herman D, Aronow WS, Nabors C. The potential impact of mammographic breast arterial calcification on physician practices in a primary care setting. Future Cardiol. 2021 Jan 12. doi: 10.2217/fca-2020-0180. Online ahead of print. PMID: 33433235
 
29.          Coritsidis GN, Aragon M, Papademetriou D, Lim B, Singh A, Karandish S. Metabolic and Quality of life Effects of Mid Dialysate Flow Rate in Hemodialysis Patients. Submitted to Blood Purification 2021.
 

Transplant
 
1.    Glicklich D, Mustafa MR. Obesity in kidney transplantation: impact on transplant candidates, recipients and donors. Cardiology in Review. 27(2): 63-72, 2019.
 
2.    Glicklich D, Shin CT, Frishman WH. Heavy   metal toxicity in chronic renal failure and cardiovascular disease: possible role for chelation. Cardiology in Review. 28(6): 1-7, November 2020.
 
3.    Glicklich D, Frishman WH. The Case for Cadmium and Lead Heavy Metal Screening. Submitted to American Journal of the Medical Sciences, 2021.
 
4.    Dhand A, Sobo SA, Wolfe K, Feola N, Lee L, Nog R, Chen D, Glicklich D, Diflo T, Nabors C. Casirivimab-Imdevimab for treatment of COVID-19 in solid organ transplant recipients: an early Experience. Transplantation, 2021, Accepted for publication
 
5.    Okumura K, Grace H, Sogawa H, Veillette G, John D, Singh N, Glicklich D, Nishida S, Diflo T. Is compensation prediction score for contralateral kidney after living donor donation useful in the United States? Submitted to Transplantation 2021

1. When are interviews typically offered?

Interviews are offered to competitive candidates by invitation only based on a review of their ERAS application.  

2. Does your program sponsor visas for international trainees??

Yes.

3. What Visa types do you accept/sponsor?

WMC sponsors J-1 visas through the ECFMG Exchange Visitor Sponsorship Program. Have in mind, all paperwork should be processed and ready before starting training in July. We consider H1B visas for exceptional candidates but this must be discussed during the interview, and the applicant must have passed USMLE Step III prior to the Rank Order list deadline. 

4. Do I have to participate in the NRMP Matching Program?

Yes. Applicants must register with the National Residency Match Program (NRMP) to participate in the Medical Subspecialty Match.  

5. Does the program offer out-of-match positions?

No, all positions are filled through the NRMP match. 

6. Does the fellowship program provide subsidized housing?

Limited housing is available for the initial year of training. An application for housing is made available to those applicants who match with the program as part of the on-boarding process. 

7. Where do fellows live?

Most of our fellows live in the city of White Plains near the hospital, or around 15-30 minutes away with some commuting from other areas. For convenience, we recommend staying near the hospital. The hospital is readily accessible via public transportation (Metro-North Railroad /bus), or by car.
 
8. Are fellows exposed to medical students directly?

Yes, medical students are assigned under the direct supervision of a fellow in the service.
It is each fellow’s responsibility to teach and guide the students, and serve as their direct supervisor.  They also provide feedback regarding student performance at the end of their rotation through evaluation forms submitted to the Clerkship Director. Fourth year sub-interns have increased responsibilities regarding patient management and education.
 
9. Does the house staff actively contribute to changes in the program?

Yes. Fellows along with the program leadership conduct regularly scheduled meetings with different post-graduate years, encouraging feedback and suggestions for on-going program improvement. Fellows have the opportunity to participate in various Departmental and hospital-wide committees. We have actively incorporated such suggestions to improve the program. Each resident and faculty member completes an Annual Feedback Evaluation questionnaire. The evaluations are reviewed by the program leadership and suggestions/comments are incorporated to improve the program.

10. Where do Westchester Nephrology graduates go after their fellowship training?

Approximately two-thirds of the graduates practice in outpatient dialysis centers and/or private practice. The remaining one-third pursue additional sub-specialty fellowship training.

11. What benefits are available to fellows at Westchester Medical Center?

Please review the House Staff Benefits Section of the Main Graduate Medical Education website. In addition to benefits provided directly by WMC, the hospital financially contributes to additional benefits via CIR (Committee of Interns and Residents). Please visit this website for a complete review of all the benefits and Educational Fund.  

12. Is your program compliant with ACGME/New York State Department of Heath duty hour regulations?

Yes. Our program schedules and fellows’ actual work hours are closely monitored to assure compliance with all duty hour regulations. 


Those interested in applying to the program must do so through the National Residency Matching Program (NRMP). Applications are accepted through the Electronic Residency Application System (ERAS) using the following link: www.aamc.org/eras.

Note that we have two NRMP program codes:
Nephrology/Clinical Program Code #: 2157148F0 (Two Year Commitment)
Nephrology/Critical Care Track - Code #: 2157148F1 (Three Year Commitment) 

In order to apply to the program, we require a complete application package to be submitted via ERAS. You must complete a three year ACGME accredited Internal Medicine residency program before starting the fellowship program. A minimum of three letters of recommendation, including one from your Internal Medicine Residency Program Director, is required.

Please access the Fellowship and Residency Electronic Interactive Database (FREIDA) for more information on our programs: https://freida.ama-assn.org/.

Interviews

The Fellowship Selection Committee will review your application after the required materials have been submitted via ERAS. Virtual Interviews will take place during the months of September and October 2021.

Visa Sponsorship

WMC will sponsor J-1 Visas. Sponsorship of H1-B Visas will be considered on a case-by-case basis for the most highly qualified applicants.

Contact Information

Marcia Ledesma
Practice Manager / Program Administrator
Advanced Nephrology Associates
19 Bradhurst Avenue, Suite 200N
Hawthorne, NY 10532
Phone: 914.493.7701 ext.3550
Fax: 914.345.0653
Email: Marcia.Ledesma@wmchealth.org